These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 33986994)

  • 1. Identification of a five-gene signature in association with overall survival for hepatocellular carcinoma.
    Yang L; Yin W; Liu X; Li F; Ma L; Wang D; Li H
    PeerJ; 2021; 9():e11273. PubMed ID: 33986994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and validation of a 14-gene signature for prognosis prediction in hepatocellular carcinoma.
    Zhang BH; Yang J; Jiang L; Lyu T; Kong LX; Tan YF; Li B; Zhu YF; Xi AY; Xu X; Yan LN; Yang JY
    Genomics; 2020 Jul; 112(4):2763-2771. PubMed ID: 32198063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of Hub Genes Associated With Immune Infiltration and Predict Prognosis in Hepatocellular Carcinoma via Bioinformatics Approaches.
    Chen H; Wu J; Lu L; Hu Z; Li X; Huang L; Zhang X; Chen M; Qin X; Xie L
    Front Genet; 2020; 11():575762. PubMed ID: 33505422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Screening core genes and cyclin B2 as a potential diagnosis, treatment and prognostic biomarker of hepatocellular carcinoma based on bioinformatics analysis].
    Yang SY; Ren H; Li CF; Tang H
    Zhonghua Gan Zang Bing Za Zhi; 2020 Sep; 28(9):773-783. PubMed ID: 33053978
    [No Abstract]   [Full Text] [Related]  

  • 5. Identification of Potential Hub Genes Related to Diagnosis and Prognosis of Hepatitis B Virus-Related Hepatocellular Carcinoma via Integrated Bioinformatics Analysis.
    Tang Y; Zhang Y; Hu X
    Biomed Res Int; 2020; 2020():4251761. PubMed ID: 33376723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Centromere protein N may be a novel malignant prognostic biomarker for hepatocellular carcinoma.
    Wang Q; Yu X; Zheng Z; Chen F; Yang N; Zhou Y
    PeerJ; 2021; 9():e11342. PubMed ID: 33987018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of a six-gene signature predicting overall survival for hepatocellular carcinoma.
    Liu GM; Zeng HD; Zhang CY; Xu JW
    Cancer Cell Int; 2019; 19():138. PubMed ID: 31139015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of Multiple Hub Genes and Pathways in Hepatocellular Carcinoma: A Bioinformatics Analysis.
    Liu J; Han F; Ding J; Liang X; Liu J; Huang D; Zhang C
    Biomed Res Int; 2021; 2021():8849415. PubMed ID: 34337056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CCNB2, CDC20, AURKA, TOP2A, MELK, NCAPG, KIF20A, UBE2C, PRC1, and ASPM May Be Potential Therapeutic Targets for Hepatocellular Carcinoma Using Integrated Bioinformatic Analysis.
    Yang Z; Wu X; Li J; Zheng Q; Niu J; Li S
    Int J Gen Med; 2021; 14():10185-10194. PubMed ID: 34992437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of molecular target genes and key pathways in hepatocellular carcinoma by bioinformatics analysis.
    Zhou L; Du Y; Kong L; Zhang X; Chen Q
    Onco Targets Ther; 2018; 11():1861-1869. PubMed ID: 29670361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification and Analysis of Potential Key Genes Associated With Hepatocellular Carcinoma Based on Integrated Bioinformatics Methods.
    Li Z; Lin Y; Cheng B; Zhang Q; Cai Y
    Front Genet; 2021; 12():571231. PubMed ID: 33767726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CCNB2, NUSAP1 and TK1 are associated with the prognosis and progression of hepatocellular carcinoma, as revealed by co-expression analysis.
    Liu L; Chen A; Chen S; Song W; Yao Q; Wang P; Zhou S
    Exp Ther Med; 2020 Apr; 19(4):2679-2689. PubMed ID: 32256749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Large-scale analysis reveals a novel risk score to predict overall survival in hepatocellular carcinoma.
    Zheng Y; Liu Y; Zhao S; Zheng Z; Shen C; An L; Yuan Y
    Cancer Manag Res; 2018; 10():6079-6096. PubMed ID: 30538557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a Novel Four-Gene Signature Correlated With the Prognosis of Patients With Hepatocellular Carcinoma: A Comprehensive Analysis.
    Zhu W; Ru L; Ma Z
    Front Oncol; 2021; 11():626654. PubMed ID: 33777771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of prognostic gene signature associated with microenvironment of lung adenocarcinoma.
    Yue C; Ma H; Zhou Y
    PeerJ; 2019; 7():e8128. PubMed ID: 31803536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening Hub Genes as Prognostic Biomarkers of Hepatocellular Carcinoma by Bioinformatics Analysis.
    Zhou Z; Li Y; Hao H; Wang Y; Zhou Z; Wang Z; Chu X
    Cell Transplant; 2019 Dec; 28(1_suppl):76S-86S. PubMed ID: 31822116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive analysis reveals a metabolic ten-gene signature in hepatocellular carcinoma.
    Zhu Z; Li L; Xu J; Ye W; Chen B; Zeng J; Huang Z
    PeerJ; 2020; 8():e9201. PubMed ID: 32518728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Global analysis of gene expression signature and diagnostic/prognostic biomarker identification of hepatocellular carcinoma.
    Wang J; Wang Y; Xu J; Song Q; Shangguan J; Xue M; Wang H; Gan J; Gao W
    Sci Prog; 2021; 104(3):368504211029429. PubMed ID: 34315286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identifying potential prognosis markers in hepatocellular carcinoma
    Hu X; Zhou J; Zhang Y; Zeng Y; Jie G; Wang S; Yang A; Zhang M
    Front Genet; 2022; 13():942454. PubMed ID: 35928445
    [No Abstract]   [Full Text] [Related]  

  • 20. An Integrated Model Based on a Six-Gene Signature Predicts Overall Survival in Patients With Hepatocellular Carcinoma.
    Li W; Lu J; Ma Z; Zhao J; Liu J
    Front Genet; 2019; 10():1323. PubMed ID: 32010188
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.